Volume 20, Number 2—February 2014
Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru
Highlight and copy the desired format.
|EID||Razuri H, Tokarz R, Ghersi BM, Salmon-Mulanovich G, Guezala M, Albujar C, et al. Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerg Infect Dis. 2014;20(2):257-260. https://dx.doi.org/10.3201/eid2002.131418|
|AMA||Razuri H, Tokarz R, Ghersi BM, et al. Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerging Infectious Diseases. 2014;20(2):257-260. doi:10.3201/eid2002.131418.|
|APA||Razuri, H., Tokarz, R., Ghersi, B. M., Salmon-Mulanovich, G., Guezala, M., Albujar, C....Montgomery, J. M. (2014). Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerging Infectious Diseases, 20(2), 257-260. https://dx.doi.org/10.3201/eid2002.131418.|
We investigated hantaviruses in rodents in the southern Amazon Basin of Peru and identified an Andes virus variant from Neacomys spinosus mice. This finding extends the known range of this virus in South America and the range of recognized hantaviruses in Peru. Further studies of the epizoology of hantaviruses in this region are warranted.
Hantaviruses are enveloped, tripartite, single-stranded, negative-sense RNA viruses belonging to the genus Hantavirus, family Bunyaviridae. More than 15 hantaviruses have been recognized in the Americas, most in South America (1). Hantaviruses are maintained in rodents and shrews, usually with a tight pairing between the specific virus and host species. On the American continents, hantaviruses can evoke a severe acute disease known as hantavirus pulmonary syndrome (HPS), which carries typical case-fatality rates of 35%–40%, depending on the particular virus (1). Hantavirus host–reservoir pairs continue to be discovered, and details of hantavirus epidemiology and the risk for transmission of hantaviruses to humans continue to emerge.
Data on hantaviruses in Peru are sparse and confined to the Loreto Region in the northern Amazon Basin (Figure 1), where a 1996 study of rodents showed a 20% prevalence of IgG to hantaviruses and the identification of a Rio Mamoré–like hantavirus from Oligoryzomys microtis rodents (2). The IgG prevalence in humans in Loreto tested during 2007–2010 was low (1.7%) (3). Nevertheless, 4 cases (3 fatal) of human hantavirus infection were reported in 2011 in this region, 2 from Rio Mamoré and 2 from Seoul virus (4,5). To expand the knowledge base on hantaviruses in Peru, we conducted an investigation of rodents in a previously unexplored area of Peru’s southern Amazon Basin.
In 2003, Peru began construction on an interoceanic highway through the southern Amazon Basin in the Peruvian administrative regions of Madre de Dios and Puno; the highway is intended to link Amazon sites with Pacific ports (Figure 1). During October 2009–October 2010, we collected small mammals at 6 sites in the region of the highway construction as part of a study exploring the effects of this construction on the region’s fauna and flora, including the risk for rodent-borne disease. This study was approved by the US Naval Medical Research Unit No. 6 Institutional Animal Care and Use Committee, and collection permits were obtained from the Peruvian Ministry of Agriculture Office of Forestry and Wildlife. Animals were collected in 6 trapping sessions by using live traps (H.B. Sherman Traps, Tallahassee, FL, USA; Tomahawk Live Trap, Hazelhurst, WI, USA) and standard methods (6). We also collected animals at a relatively undisturbed site near the Tambopata National Reserve (Figure 1). Animals were anesthetized and euthanized before morphometric measurements were taken and necropsies performed. Samples of blood, heart, lung, spleen, liver, and kidney were collected (7); tissues were stored in liquid nitrogen for transport to the laboratory. A section of liver was also preserved in 95% ethanol for molecular identification of rodent species. Rodent carcasses were fixed in 10% formalin and preserved in 70% ethanol as permanent voucher specimens.
Rodent blood was tested by ELISA for IgG to New World hantaviruses at the Centers for Disease Control and Prevention Special Pathogens Branch in Atlanta, Georgia, USA, by using nucleocapsid antigen derived from Sin Nombre virus, which is broadly cross-reactive among New World hantaviruses (6). Nested reverse transcription PCR (RT-PCR) was performed by Naval Medical Research Unit No. 6 on homogenized lung samples from IgG-positive rodents. PCR targetED a 434-bp region of the hantavirus small (S) segment and 296- and 242-bp regions of the medium (M) segment G1 and G2 regions, respectively (8). Ion Torrent Personal Genome Machine (Life Technologies, Carlsbad, CA, USA) high-throughput sequencing and additional consensus RT-PCR on ELISA-positive rodents were performed at Columbia University in New York, NY, USA. Rodent species was determined on the basis of morphometric assessment by experienced mammalogists at the San Marcos University Natural History Museum in Lima, Peru; identification of IgG-positive animals was confirmed by DNA extraction from the liver followed by PCR amplification and sequencing of the cytochrome b gene (9).
During a total of 15,145 trap-nights, 362 rodents (trapping success rate 2.4%) belonging to 14 species were captured. The most frequently trapped rodents were 155 (42.8%) Oligoryzomys microtis mice, 49 (13.5%) Necromys lenguarum mice, 41 (11.3%) Hylaeamys spp. rodents, 35 (9.7%) Euryoryzomys nitidus rats, and 34 (9.4%) Neacomys spinosus mice. Six (1.7%) rodents had positive results for hantavirus IgG: 2 N. spinosus mice (both adult males), 2 N. lenguarum mice (1 adult and 1 juvenile, both females), 1 H. yunganus rat (juvenile female), and 1 E. nitidus rat (adult male). IgG-positive rodents were trapped at 5 times from 3 sites at distances 43–145 km from Puerto Maldonado, the capital city of Madre de Dios.
Results of RT-PCR testing were positive for 2 of 6 IgG-positive rodents, the 2 N. spinosus mice, which were trapped on consecutive days at the same site, 80 km from Puerto Maldonado. However, a hantavirus sequence was identified in only 1 of these rodents by both consensus RT-PCR and high-throughput sequencing. Assembly of hantavirus reads obtained by high-throughput sequencing resulted in the generation of 1,068 bp of the S, 1,673 bp of the M, and 572 bp of the large (L) segments for the virus. Phylogenetic analysis showed the virus to be an Andes virus clade variant most similar to viruses within the Castelo dos Sonhos (CASV) group, which consists of CASV and CASV-2, found in Brazil, and Tunari virus (TUNV), found in Bolivia (Figure 2) (10). The nucleotide sequences of the S and M segments were 91% and 90%, respectively, identical to TUNV (98% and 97% aa identity, respectively). The L segment sequence was most similar to CASV-2 (85% nt and 98% aa identity). No TUNV L segment sequence data are available for comparison. The S, M, and L nucleotide sequences for the virus we identified were deposited in GenBank under accession nos. KF581134, KF581135, and KF581136, respectively.
Our data confirm the presence of an Andes virus variant similar to TUNV and CASV in the southern Amazon Basin of Peru; this finding extends the known range of this virus in South America and the range of recognized hantaviruses in Peru. HPS has been associated with CASV in Brazil (11,12) and with TUNV in Bolivia (13). However, no cases have been reported in the southern Amazon Basin of Peru, nor is formal surveillance for the disease conducted in the area, and no human antibody prevalence studies have been conducted. The lack of reported human cases could mean that the frequency of infected rodents, or of human contact with them, is low; that human infection occurs but is asymptomatic or too mild to be recognized; or that HPS is misdiagnosed by clinicians who are unfamiliar with the condition and lack access to diagnostic testing. In some areas of South America, including Bolivia, Paraguay, Argentina, and Chile, a high prevalence of hantavirus IgG in humans has been reported, but reports of cases of HPS have been infrequent (14).
Oligoryzomys spp. rodents appear to be the principal reservoirs for most Andes viruses, including CASV (12,15); no reservoir has been associated with TUNV. Our data suggest that N. spinosus mice may be the reservoir for the Andes virus variant found in Madre de Dios and Puno, although spillover infection from an alternate reservoir cannot be excluded. If these mice are the reservoir for this virus, the human population at risk for hantavirus infection by transmission from N. spinosus mice could be large, because the range of this species encompasses considerable portions of Brazil, Colombia, Ecuador, Peru, and Bolivia. N. spinosus mice have not been associated with other hantaviruses. Further investigation of the epizoology of hantaviruses and possible risks to humans in the southern Amazon Basin of Peru is warranted.
Dr Razuri is a physician from Peru and is now working as a research coordinator at the Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada. His area of focus is the epidemiology of infectious diseases, including HIV/AIDS, influenza, and zoonotic diseases.
The authors thank James Mills for expert review of the manuscript and Cecilia Gonzales for administrative assistance.
This project was supported by awards to United States Naval Medical Research Unit No. 6 from the Armed Forces Health Surveillance Center Global Emerging Infections Surveillance and Response System (work unit no. 847705 82000 25GB B0016) and to Columbia University from the National Institutes of Health National Institute of Allergy and Infectious Diseases, the United States Agency for International Development, the PREDICT project, and Defense Threat Reduction Agency.
The experiments reported herein were conducted in compliance with the Animal Welfare Act and in accordance with the principles set forth in the 1996 edition of the National Research Council’s Guide for the Care and Use of Laboratory Animals (www.nap.edu/openbook.php?record_id=5140). Animal collection was authorized by the Peru Office of Forestry and Wildlife through permit nos. RJ 002-2010-SERNANP-DGANP-PNBS, RD 383-2009-AG-DGFFS-DGEFFS, and RD 425-2010-AG-DGFFS-DGEFFS. Exportation authorization of serum samples was issued by the same office, permit no. 004546-AG-DGFFS and 412-2013-MINAGRI 00456-AGDGFFS/DGEFSS.
- Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010;23:412–41 .
- Powers AM, Mercer DR, Watts DM, Guzman H, Fulhorst CF, Popov VL, Isolation and genetic characterization of a hantavirus (Bunyaviridae: Hantavirus) from a rodent, Oligoryzomys microtis (Muridae), collected in northeastern Peru. Am J Trop Med Hyg. 1999;61:92–8 .
- Castillo Oré RM, Forshey BM, Huaman A, Villaran MV, Long KC, Kochel TJ, Serologic evidence for human hantavirus infection in Peru. Vector Borne Zoonotic Dis. 2012;12:683–9.
- Casapía M, Mamani E, Garcia MP, Miraval ML, Valencia P, Quino AH, Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region [in Spanish]. Rev Peru Med Exp Salud Publica. 2012;29:390–5.
- García PM, Percy S, Herrera AL, Donaires F, Alvarez C, Arrasco J, Etiologic confirmation of the first two cases of human hantavirosis in Peru [in Spanish]. Rev Peru Med Exp Salud Publica. 2011;28:566–7.
- Carroll DS, Mills JN, Montgomery JM, Bausch DG, Blair PJ, Burans JP, Hantavirus pulmonary syndrome in central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes. Am J Trop Med Hyg. 2005;72:42–6 .
- Mills JN, Yates TL, Childs JE, Parmenter RR, Ksiazek TG, Rollin PE, Guidelines for working with rodents potentially infected with hantavirus. J Mammal. 1995;76:716–22.
- Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology. 1997;238:115–27.
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–10 .
- Firth C, Tokarz R, Simith DB, Nunes MR, Bhat M, Rosa ES, Diversity and distribution of hantaviruses in South America. J Virol. 2012;86:13756–66.
- Johnson AM, de Souza LT, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol. 1999;59:527–35.
- Medeiros DB, da Rosa ES, Marques A, Simith DB, Carneiro AR, Chiang JO, Circulation of hantaviruses in the influence area of the Cuiaba-Santarem Highway. Mem Inst Oswaldo Cruz. 2010;105:665–71.
- Cruz CD, Forshey BM, Vallejo E, Agudo R, Vargas J, Blazes DL, Novel strain of Andes virus associated with fatal human infection, central Bolivia. Emerg Infect Dis. 2012;18:750–7.
- Montgomery JM, Blair PJ, Carroll DS, Mills JN, Gianella A, Iihoshi N, Hantavirus pulmonary syndrome in Santa Cruz, Bolivia: outbreak investigation and antibody prevalence study. PLoS Negl Trop Dis. 2012;6:e1840.
- Travassos da Rosa ES, Medeiros DB, Nunes MR, Simith DB, de Souza Pereira A, El Khoury MR, Pygmy rice rat as potential host of Castelo dos Sonhos hantavirus. Emerg Infect Dis. 2011;17:1527–30.
- Figure 1. . Regions of Peru, indicating areas of previous hantavirus study (Loreto ) and the study of hantaviruses described in this article (Madre de Dios and Puno). Capital cities of...
- Figure 2. . Maximum likelihood phylogenetic trees of the small (S; panel A) and medium (M; panel B) segments of the hantavirus identified in this study in Peru (boldface) compared with...
1Current affiliation: McGill University Health Centre, Montreal, Quebec, Canada.
2These authors contributed equally to this article.
3These authors jointly supervised this work.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Hugo Razuri, McGill University Health Centre, Royal Victoria Hospital Campus, 687 Pine Avenue West, V-Building, Rm V208, Montreal, QC H3A1A1, CanadaHugo Razuri, McGill University Health Centre, Royal Victoria Hospital Campus, 687 Pine Avenue West, V-Building, Rm V208, Montreal, QC H3A1A1, Canada
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: January 17, 2014
- Page last updated: January 17, 2014
- Page last reviewed: January 17, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)